Cranbury

Systech International and Zetes Partner to Meet Europe’s Emerging Pharmaceutical Regulatory Requirements

Cornerstone Pharmaceuticals Appoints Dr. Dorit Arad Director of Research and Development for its Israeli Operations

BlackLight Power, Inc. Announces Independent Validation of Breakthrough New Energy Source Based on a New Form of Hydrogen and Chemistry Capable of Continuous Regeneration

BlackLight Power Inc. Announces its Sixth Commercial License Agreement

/C O R R E C T I O N — BlackLight Power/

CRANBURY, New Jersey, September 1, 2011 - Systech International, the recognized global leader in Serialization, and Zetes, a leading European system integrator and provider of innovative supply chain, identification and mobility solutions and services, today announced their partnership.

MORE..

CRANBURY, New Jersey, August 17, 2010 - Cornerstone Pharmaceuticals, Inc., the cancer metabolism company, today announced that Dorit Arad, Ph.D., has been appointed director of research and development for the company's operations in Israel.

MORE..

CRANBURY, New Jersey - - BlackLight Power Physics Grand Slam: Power, Hydrinos, Light Signature, Theory Prediction Validated BlackLight Power, Inc.

MORE..

CRANBURY, New Jersey - - Non-Exclusive License with Akridge Energy to produce up to 400 MW of continuous power BlackLight Power (BLP) Inc.

MORE..

Older News

CRANBURY, New Jersey - In the news release, "BlackLight Power Inc.

MORE..